# A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)

> **NCT01273467** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 13 (actual)

## Conditions studied

- Stroke
- Ischemia
- Infarction

## Interventions

- **DRUG:** CNTO 0007 or placebo (Stage A)
- **DRUG:** CNTO 0007 or placebo (Stage B)

## Key facts

- **NCT ID:** NCT01273467
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-12
- **Primary completion:** —
- **Final completion:** 2013-07
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2014-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01273467

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01273467, "A Safety and Tolerability Study of 42037788 (Referred to as CNTO 0007) Compared With Placebo in Patients Who Have Experienced Ischemic Cerebral Infarction (Also Known as Stroke)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01273467. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*